Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-4-amino-2-((3R,6S,9S,12S,15R,E)-15-((3S,6S,9S,12S)-1-((3S,6S,9R,18R,21S,24S,29aS,E)-18-((S)-2-amino-3-hydroxypropanamido)-3-(3-amino-3-oxopropyl)-21-(2-carboxyethyl)-24-((R)-1-hydroxyethyl)-6-methyl-1,4,7,19,22,25-hexaoxo-2,3,4,5,6,7,8,9,10,12,15,17,18,19,20,21,22,23,24,25,27,28,29,29a-tetracosahydro-1H-pyrrolo[2,1-l][1,23,4,7,10,13,16,19]dithiahexaazacycloheptacosin-9-yl)-12-(3-guanidinopropyl)-3,9-bis((R)-1-hydroxyethyl)-6-isobutyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatridecanamido)-6-(3-amino-3-oxopropyl)-12-((S)-sec-butyl)-9-((R)-1-hydroxyethyl)-5,8,11,14-tetraoxo-1,17-dithia-4,7,10,13-tetraazacyclohenicos-19-ene-3-carboxamido)-4-oxobutanoic acid
ID: ALA5206023
PubChem CID: 168296750
Max Phase: Preclinical
Molecular Formula: C84H138N24O29S4
Molecular Weight: 2076.44
Associated Items: